Clinical trial
Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension
NCT01489670 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension
- Lead sponsor
- Allergan
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2011
- Completion date
- March 31, 2013
- Enrollment
- 387 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.